Publication date: Jul 27, 2023
The COVID-19 pandemic resulted in daily functioning changes for many families. Adjustments in daily functioning may have impacted asthma management and subsequent morbidity. The current study seeks to build upon extant literature by exploring differences in youth asthma exacerbations and control, as well as youth and caregiver asthma-related quality of life (ArQOL) throughout COVID-19 transitional points. Ninety-three youth (9-17 years old) with asthma and their caregivers completed measures of demographic/medical information, asthma control, and ArQOL. Participants were recruited between January 2020 and October 2021 via their medical appointments and a hospital registry. We conducted Kruskal-Wallis H-tests to examine differences in youth asthma exacerbations (measured by short-acting beta agonist use), asthma control, and ArQOL, as well as caregiver ArQOL, across phases of the COVID-19 pandemic. Asthma exacerbations were higher prior to the onset of the pandemic compared to “during lockdown” and “post-lockdown,” H(2)ā=ā7. 31, pā
Open Access PDF
Concepts | Keywords |
---|---|
Caregivers | asthma control |
Covid | asthma exacerbation |
Daily | COVID-19 |
October | pediatrics |
Pandemic | quality of life |
Semantics
Type | Source | Name |
---|---|---|
disease | MESH | asthma |
pathway | KEGG | Asthma |
disease | IDO | quality |
disease | MESH | COVID-19 pandemic |
disease | MESH | morbidity |
disease | MESH | Allergy |
pathway | REACTOME | Reproduction |
disease | MESH | psychosocial functioning |
disease | VO | Viruses |
disease | MESH | complications |
disease | VO | frequency |
disease | MESH | emergency |
drug | DRUGBANK | Medical air |
drug | DRUGBANK | Salbutamol |
disease | MESH | chronic condition |
disease | MESH | cystic fibrosis |
disease | MESH | cognitive impairment |
drug | DRUGBANK | Etoperidone |
drug | DRUGBANK | Methionine |
disease | VO | protocol |
disease | VO | report |
disease | MESH | exercise induced asthma |
drug | DRUGBANK | Pentaerythritol tetranitrate |